Hypokalaemia and sudden cardiac death - Lessons from implantable cardioverter defibrillators

Emergency Medicine Journal

Volumn 24, Issue 3, 2007, Pages 206-208

  Maeder, Micha ^a   Rickli, Hans ^a   Sticherling, Christian ^b   Widmer, Regula ^a   Ammann, Peter ^a  

^a Division of Cardiology   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMILORIDE; AMIODARONE; ATENOLOL; BUTIZIDE; FUROSEMIDE; HYDROCHLOROTHIAZIDE; INSULIN; ISOSORBIDE MONONITRATE; LOOP DIURETIC AGENT; METOLAZONE; PANTOPRAZOLE; PERINDOPRIL; PHENPROCOUMON; POTASSIUM; POTASSIUM SPARING DIURETIC AGENT; PRAVASTATIN; SIMVASTATIN; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TORASEMIDE; VALSARTAN;

ADULT; AGED; ARTICLE; CASE REPORT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEFIBRILLATOR; DISEASE ASSOCIATION; DISEASE SEVERITY; DIURETIC THERAPY; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GYNECOMASTIA; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE FAILURE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; HYDRATION; HYPERTENSION; HYPOKALEMIA; IMPLANT; MALE; MONOTHERAPY; PERIPHERAL EDEMA; PRIORITY JOURNAL; SUDDEN DEATH; TREATMENT RESPONSE;

AGED; ARRHYTHMIA; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; DIURETICS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPOKALEMIA; MALE; MIDDLE AGED;

EID: 34147186699     PISSN: 14720205     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.2006.044073     Document Type: Article

References (9)

1. Gennari FJ. Hypokalemia. N Engl J Med 1998; 339:451-8.
2. Macdonald JE, Struthers AD. What is the optimal serum potassium level in cardiovascular patients? J Am Coll Cordiol 2004; 43:155-61.
3. Cooper HA, Dries DL, Davies CE, et al. Diuretics and risk of arrkythmic death in patients with left ventricular dysfunction. Circulation 1999;100:1311-15.
4. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blacker vs. diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), JAMA 2002; 288:2981-97.
5. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991;265:3255-64.
6. Brater DC. Diuretic therapy. N Engl J Med 1998; 339:387-95.
7. Svensson M, Gustafsson F, Galatius S, et al. Hyperkalaemia and impaired renal function in patients taking spironoloctone for congestive heart failure: retrospective study. BMJ 2003; 327:1141-2.
8. Juudink DN, Mamdani MM, Lee DS, et al. Rates of hyperkalemia after publication of the randomized aldactone evaluation study. N Engl J Med 200,4;351:543-51.
9. Siscovick DS, Raghunathan TE, Psaty BM, et al. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 1994;330:1852-7.